Stifel Financial
GBT

Stifel Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Stifel Financial’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,436
Closed -$205K – 3423
2022
Q2 		$205K Buy
6,436
+323
+5% +$9.46K ﹤0.01% 2988
2022
Q1 		$211K Sell
6,113
-18,303
-75% -$547K ﹤0.01% 3098
2021
Q4 		$715K Buy
24,416
+2,517
+11% +$78K ﹤0.01% 2373
2021
Q3 		$558K Buy
21,899
+13,962
+176% +$410K ﹤0.01% 2519
2021
Q2 		$278K Sell
7,937
-651
-8% -$25.4K ﹤0.01% 2948
2021
Q1 		$350K Buy
8,588
+227
+3% +$10.4K ﹤0.01% 2695
2020
Q4 		$362K Buy
8,361
+1,633
+24% +$80.5K ﹤0.01% 2507
2020
Q3 		$371K Sell
6,728
-10,054
-60% -$639K ﹤0.01% 2271
2020
Q2 		$1.06M Buy
16,782
+1,466
+10% +$101K ﹤0.01% 1516
2020
Q1 		$779K Sell
15,316
-2,058
-12% -$138K ﹤0.01% 1587
2019
Q4 		$1.38M Buy
17,374
+4,206
+32% +$249K ﹤0.01% 1595
2019
Q3 		$629K Buy
13,168
+1,298
+11% +$67.6K ﹤0.01% 2036
2019
Q2 		$618K Buy
11,870
+419
+4% +$24.1K ﹤0.01% 2098
2019
Q1 		$599K Buy
11,451
+439
+4% +$21.6K ﹤0.01% 1963
2018
Q4 		$439K Buy
+11,012
New +$413K ﹤0.01% 2006

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stifel Financial's GBT Position: Q3 2022 in Review

Stifel Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 6,436 shares — an estimated $205K sold.

Stifel Financial first reported a position in GBT in Q4 2018 and held it in 15 quarters. The position peaked at $1.38M in Q4 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Stifel Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Stifel Financial sold 6,436 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $205K.
  • Stifel Financial first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 15 quarters.
  • Stifel Financial's Global Blood Therapeutics, Inc. position peaked at $1.38M in Q4 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Stifel Financial's 13F filing for Q3 2022, filed 14 Nov 2022.